Moreover, doxorubicin damages lysosomal function, resulting in the incomplete execution of the transcription factor EB (TFEB)‐driven autophagy programme, the obstruction of autophagosome‐lysosomal fusion, causing left ventricular atrophy and heart failure, and ultimately increasing mortality [69]. The gene discussed is TFEB; the disease is heart failure.